Endoscopic ablation for benign enlargement of the prostate

Editorial

Sean P Elliott. BMJ. 2008.

. 2008 Jun 30;337(7660):a535.

doi: 10.1136/bmj.39582.425417.BE.

Abstract

Newer techniques are no better than transurethral resection, but the evidence base is poor

Competing interests: None declared.

Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials.
Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, N'Dow J; Benign Prostatic Enlargement team. Lourenco T, et al. BMJ. 2008 Jun 30;337(7660):a449. doi: 10.1136/bmj.39575.517674.BE. BMJ. 2008. PMID: 18595932 Free PMC article.

1. Guess HA, Arrighi HM, Metter EJ, Fozzard JL. The cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990;17:241-6. - PubMed
1. Guess HA, Chute CG, Garraway WM, Girman CJ, Panser LA, Lee RJ, et al. Similar levels of urological symptoms have similar impact on Scottish and American men although Scots report less symptoms. J Urol 1993;150:1701-5. - PubMed
1. Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol 1994;151:1266-70. - PubMed
1. Tsukamoto T, Kumamoto Y, Masumori N, Miyake H, Rhodes T, Girman CJ, et al. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995;154(2 Pt 1):391-5. - PubMed
1. Nacey JN, Morum P, Delahunt B. Analysis of the prevalence of voiding symptoms in Maori, Pacific Island and Caucasian New Zealand men. Urology 1995;46:506-11. - PubMed